» Articles » PMID: 34359959

Cerebral Organoids-Challenges to Establish a Brain Prototype

Overview
Journal Cells
Publisher MDPI
Date 2021 Aug 7
PMID 34359959
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The new cellular models based on neural cells differentiated from induced pluripotent stem cells have greatly enhanced our understanding of human nervous system development. Highly efficient protocols for the differentiation of iPSCs into different types of neural cells have allowed the creation of 2D models of many neurodegenerative diseases and nervous system development. However, the 2D culture of neurons is an imperfect model of the 3D brain tissue architecture represented by many functionally active cell types. The development of protocols for the differentiation of iPSCs into 3D cerebral organoids made it possible to establish a cellular model closest to native human brain tissue. Cerebral organoids are equally suitable for modeling various CNS pathologies, testing pharmacologically active substances, and utilization in regenerative medicine. Meanwhile, this technology is still at the initial stage of development.

Citing Articles

A comprehensive review of electrophysiological techniques in amyotrophic lateral sclerosis research.

Ren K, Wang Q, Jiang D, Liu E, Alsmaan J, Jiang R Front Cell Neurosci. 2024; 18:1435619.

PMID: 39280794 PMC: 11393746. DOI: 10.3389/fncel.2024.1435619.


Human cortical spheroids with a high diversity of innately developing brain cell types.

De Kleijn K, Zuure W, Straasheijm K, Martens M, Avramut M, Koning R Stem Cell Res Ther. 2023; 14(1):50.

PMID: 36959625 PMC: 10035191. DOI: 10.1186/s13287-023-03261-3.


Telencephalon Organoids Derived from an Individual with ADHD Show Altered Neurodevelopment of Early Cortical Layer Structure.

Zhang D, Eguchi N, Okazaki S, Sora I, Hishimoto A Stem Cell Rev Rep. 2023; 19(5):1482-1491.

PMID: 36872412 PMC: 10366301. DOI: 10.1007/s12015-023-10519-z.


Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy.

Jurcau A, Jurcau M Biomedicines. 2022; 10(8).

PMID: 36009443 PMC: 9405755. DOI: 10.3390/biomedicines10081895.


Molecular Pathophysiological Mechanisms in Huntington's Disease.

Jurcau A Biomedicines. 2022; 10(6).

PMID: 35740453 PMC: 9219859. DOI: 10.3390/biomedicines10061432.


References
1.
Izsak J, Seth H, Andersson M, Vizlin-Hodzic D, Theiss S, Hanse E . Robust Generation of Person-Specific, Synchronously Active Neuronal Networks Using Purely Isogenic Human iPSC-3D Neural Aggregate Cultures. Front Neurosci. 2019; 13:351. PMC: 6491690. DOI: 10.3389/fnins.2019.00351. View

2.
Azmitia E, Whitaker-Azmitia P, Bartus R . Use of tissue culture models to study neuronal regulatory trophic and toxic factors in the aged brain. Neurobiol Aging. 1988; 9(5-6):743-58. DOI: 10.1016/s0197-4580(88)80142-8. View

3.
Wilson E, Newell-Litwa K . Stem cell models of human synapse development and degeneration. Mol Biol Cell. 2018; 29(24):2913-2921. PMC: 6329912. DOI: 10.1091/mbc.E18-04-0222. View

4.
Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View

5.
Camp J, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Brauninger M . Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci U S A. 2015; 112(51):15672-7. PMC: 4697386. DOI: 10.1073/pnas.1520760112. View